A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro
Utipro® Plus
antimicrobial resistance
antimicrobial stewardship
quality of life
recurrent urinary tract infections
Journal
Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
02
2021
accepted:
13
04
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
6
2021
Statut:
epublish
Résumé
Recurrent urinary tract infections (UTIs) can profoundly impair patients' quality of life and carry a substantial health resource burden. Although antibiotics are the mainstay of treatment, interest is growing in identifying antibiotic-sparing alternatives. Utipro
Identifiants
pubmed: 34104200
doi: 10.7573/dic.2021-2-2
pii: dic-2021-2-2
pmc: PMC8152786
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
Copyright © 2021 Cai T, Konstantinidis C, Ward S.
Déclaration de conflit d'intérêts
Disclosure and potential conflicts of interest: TC has received travelling and speaking grants from Noventure. CKG has served as a freelance medical advisor for pharmaceutical and biotech companies including Devicare, Ferrer and Noventure. SW has served as a consultant for Goodlife (propiverine) and Merck (Cran Fyt Plus). The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/05/dic.2021-2-2-COI.pdf
Références
Future Microbiol. 2017 Jun;12:721-731
pubmed: 28345957
Future Microbiol. 2017 Mar;12:239-246
pubmed: 28262045
Future Microbiol. 2016 May;11:651-8
pubmed: 27022857
Clin Infect Dis. 2012 Sep;55(6):771-7
pubmed: 22677710
Ther Adv Urol. 2019 May 02;11:1756287218814382
pubmed: 31105772
Asian Pac J Trop Biomed. 2014 Feb;4(2):104-8
pubmed: 25182280
Clin Infect Dis. 2015 Dec 1;61(11):1655-61
pubmed: 26270684
Future Microbiol. 2017 May;12:505-513
pubmed: 28326812
Infect Dis Ther. 2015 Dec;4(4):417-23
pubmed: 26507395
Future Microbiol. 2019 Aug;14:1013-1021
pubmed: 31469009
Ther Adv Urol. 2019 May 02;11:1756287219832172
pubmed: 31105774
Arch Gynecol Obstet. 2019 Oct;300(4):821-828
pubmed: 31350663
Infect Dis Clin North Am. 2014 Mar;28(1):1-13
pubmed: 24484571
Arch Ital Urol Androl. 2017 Mar 31;89(1):1-6
pubmed: 28403585
Int J Mol Sci. 2018 Feb 27;19(3):
pubmed: 29495535
BMC Res Notes. 2011 Nov 29;4:522
pubmed: 22126300